
Suven Life Sciences Ltd is Rated Sell
2026-11-13 10:10:45Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Suven Life Sciences Ltd is Rated Sell
2026-11-02 10:10:25Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Suven Life Sciences Ltd is Rated Sell
2026-10-22 10:10:26Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Suven Life Sciences Ltd Surges 8.85% to Day's High of Rs 308.05 — Outperforms Sector by 7.56 Percentage Points
2026-10-15 11:31:28The Sensex climbed 1.59% on 15 Oct 2026, yet Suven Life Sciences Ltd outpaced the broader market with an 8.85% gain, reaching an intraday high of Rs 308.05. This 7.56-percentage-point outperformance over its Healthcare Services sector signals a distinctly stock-specific rally rather than a market-wide lift.
Read More
Suven Life Sciences Ltd is Rated Sell
2026-10-11 10:10:15Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Suven Life Sciences Ltd is Rated Sell
2026-09-30 10:10:30Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Suven Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-09-21 08:01:53Suven Life Sciences Ltd, a small-cap player in the Healthcare Services sector, has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s price momentum and technical indicators reveal a cautiously optimistic outlook amid ongoing market volatility.
Read More
Suven Life Sciences Ltd is Rated Sell
2026-09-19 10:10:20Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Suven Life Sciences Ltd Shows Bullish Technical Momentum Amid Mixed Indicator Signals
2026-09-18 08:02:32Suven Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent upgrade in its technical outlook, the stock continues to display a complex interplay of indicator signals, reflecting both strength and caution for investors navigating the healthcare services sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
16-Nov-2026 | Source : BSEPlease find enclosed the Revised News Release of our company
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16-Nov-2026 | Source : BSEPlease find enclosed the News Release of our Company
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12-Nov-2026 | Source : BSEPlease find enclosed News Release of our Company
Corporate Actions
No Upcoming Board Meetings
Suven Life Sciences Ltd has declared 150% dividend, ex-date: 14 Feb 19
Suven Life Sciences Ltd has announced 1:2 stock split, ex-date: 23 Mar 07
Suven Life Sciences Ltd has announced 1:1 bonus issue, ex-date: 23 Mar 07
Suven Life Sciences Ltd has announced 1:2 rights issue, ex-date: 17 Oct 22